Home   >  
Angiogenesis/Protein Tyrosine Kinase
  • Jak/Stat Pathway
  • Wnt/Stem Cell
  • Epigenetics
  >  
JAK
  >   BMS-911543
BMS-911543 Chemical Structure

BMS-911543

Data Sheet For research use only. Not for human use.
Cat. No. :BCP07258CAS No. :1271022-90-2Purity:98%
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 1271022-90-2 Cat. No. BCP07258
Name BMS-911543
Synonyms BMS911543;BMS 911543;
SMILES
Chemical Name
Formula C23H28N8O M. Wt 432.52
Purity 98% Storage Store at 4-8°C
Description BMS-911543 is a pyrrolopyridine small-molecule inhibitor. Dissociation constants of BMS-911543 for JAK1, JAK2 and JAK3 extended these findings and displays a broader selectivity for JAK2 with Ki values of 1114, 0.48 and 357?nm, respectively. Outside the JAK family, the highest inhibitory activity is observed for the Src family member, Lyn (IC50=300?nm), and the c-FMS receptor tyrosine kinase (IC50=450?nm), which are both significantly less sensitive than JAK2 (>250-fold). In JAK2V617F-dependent cells such as SET2 or Ba/F3 engineered to express JAK2V617F, BMS-911543 treatment resulted in a dose-dependent anti-proliferative effect with IC50 values of 60 and 70?nm, respectively. BMS-911543 suppresses the growth of MPN patient-derived cells. In the presence of EPO, BFU-E IC50s for BMS-911543 in MPN-patient cells rangs from <0.150 to ~0.9?μm, indicating an increased sensitivity to JAK2 inhibition compared with normal healthy volunteers. BMS-911543 inhibits TPO-stimulated JAK2WT-pSTAT5 activ
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:BMS-911543 supplier,BMS-911543 purchase,BMS-911543 manufacturer,BMS-911543 distributor,BMS-911543 cost,BMS-911543 buy,BMS-911543 for sale

0086-13720134139